Company
neurogene.com
Neurogene - Developing Purpose - built Genetic Medicines
Also known as Neurogene Inc
- Business model
- B2B
- Legal name
- Neurogene Inc
Claim, correct or request removal
Record updated 29 September 2026
About
At Neurogene, our mission is to turn devastating neurological diseases into treatable conditions, to improve the lives of patients and families impacted by these rare diseases.
Funding snapshot
- Total raised
- $106MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $69M2020-12-15
Funding rounds
- Round, 2020
- $69M2020-12-15, SEC form D sold, 32 investors
- Round, 2019
- $37.5M2019-02-08, SEC form D sold, 13 investors
Loading relationship preview